Charles Dumontet

Université Claude Bernard Lyon 1 — France

Medicine · Health Sciences

79h-index30.0kcitations711works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(115), Chronic Lymphocytic Leukemia Research(86), Monoclonal and Polyclonal Antibodies Research(72), Microtubule and mitosis dynamics(70), Lymphoma Diagnosis and Treatment(64)

Publications707 total

Fibrillarin Contributes to the Oncogenic Characteristics of Colorectal Cancer Cells and Reduces Sensitivity to 5-Fluorouracil
Cancers·2025Open Access
DIS3 licenses B cells for plasma cell differentiation in humans
Cellular and Molecular Immunology·2025Open Access
Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases
Leukemia·2025
Exploring and bypassing resistance to targeted therapies in colorectal cancer
Biomedicine & Pharmacotherapy·2025· 2 citedOpen Access
Whole-Exome Sequencing-Based Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Pedigrees
Cancers·2025Open Access
Beyond Rodents: Alternative Animal Models in Colorectal Cancer Research
International Journal of Molecular Sciences·2025· 2 citedOpen Access
Évaluation de nouveaux marqueurs de suivi, de réponse ainsi que l’effet sur les cellules cancéreuses circulante du traitement focal par HIFU
Progrès en Urologie - FMC·2025
Durable Responses With Front‐Line Rituximab in Autoimmune Cytopenias Associated With Indolent B‐Cell Clones
American Journal of Hematology·2025Open Access
Effect of a systemically administered innate immune modulator on anti-tumor activity against metastatic osteosarcoma.
Journal of Clinical Oncology·2025
Netrin‐1 and B‐cell maturation antigen expression in a large cohort of 361 lymphomas: sensitive and specific staining in plasmablastic lymphomas, and therapeutic perspectives
The Journal of Pathology Clinical Research·2025Open Access
SLX4 and XPF are involved in cell migration and EMT in a cell-specific manner
Biochemical Pharmacology·2025· 1 cited
80P A systemically administered innate immune modulator displays potent anti-tumor activity against metastatic osteosarcoma
ESMO Open·2025Open Access
The synergy between alkylating agents and ERCC1–XPF inhibitors is p53 dependent
Fundamental and Clinical Pharmacology·2024· 4 citedOpen Access
Expanded Genome-Wide Association Study (GWAS) Identifies Nine Novel Germline Risk Loci for Waldenström Macroglobulinemia (WM) and Lymphoplasmacytic Lymphoma (LPL)
Blood·2024Open Access
End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy
Frontiers in Oncology·2024Open Access
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma
Blood·2024· 22 citedOpen Access
Unlocking the potential of bio-inspired bioinks: A collective breakthrough in mammalian tissue bioprinting
Bioprinting·2024· 8 citedOpen Access
The landscape of rare genetic variants in familial Waldenström macroglobulinemia
Blood Neoplasia·2024· 3 citedOpen Access
Unlocking the potential of bio-inspired bioinks: A collective breakthrough in mammalian tissue bioprinting
2024· 2 citedOpen Access
Combined effects of exercise and immuno-chemotherapy treatments on tumor growth in MC38 colorectal cancer-bearing mice
Frontiers in Immunology·2024· 9 citedOpen Access
page 1 of 36Next →

Frequent Co-authors

Gilles Salles(9), Bertrand Coiffier(9), Catherine Thiéblemont(8), John R. Mackey(8), P. Sève(7), Pascale Felman(6), Isabelle Moullet(5), Thierry Façon(4), Carlos M. Galmarini(4), Fadhela Bouafia(4), F Berger(4), Alain Beck(3), Lars Petter Jordheim(3), Michel Attal(3), Gérald Marit(3), Denis Caillot(3), Philippe Moreau(3), Cyrille Hulin(3), Laurent Garderet(3), Serge Leyvraz(3)